BSX

Boston Scientific
D

BSX

Arincen84/100B

Boston Scientific operating income 1991–2026

Boston Scientific's operating income in Q3 FY2026, the three months to 30 September 2026, was 979.00M USD, down 6.8% on the same quarter a year before. Boston Scientific's operating income over the last twelve months was 4.44B USD, up 32.2% on the twelve months before. In fiscal year 2025 it was 3.97B USD, up 50.7% on the year before.

Last updated 7 Nov 2026 · Next report 3 Feb 2027

Operating income

Operating income · +17.5% a year over 10 yearsOperating margin

Growth

Fiscal yearPeriod endingOperating incomeGrowthOperating marginGross profitGross marginEBITDA
TTM30 Sept 20264.44B+32.23%21.05%14.83B70.37%5.41B
FY202531 Dec 20253.97B+50.70%19.78%13.85B69.01%5.10B
FY202431 Dec 20242.64B+20.82%15.73%10.27B61.31%3.94B
FY202331 Dec 20232.18B+19.57%15.32%8.83B62.02%3.45B
FY202231 Dec 20221.82B-5.10%14.38%7.71B60.83%2.74B
FY202131 Dec 20211.92B+219.80%16.17%7.46B62.76%2.52B
FY202031 Dec 2020601.00M-64.89%6.06%5.58B56.25%1.51B
FY201931 Dec 20191.71B-1.44%15.95%6.88B64.08%2.21B
FY201831 Dec 20181.74B+13.90%17.68%6.48B65.94%2.59B
FY201731 Dec 20171.53B+23.38%16.85%5.87B64.89%2.01B
FY201631 Dec 20161.24B+56.46%14.74%5.34B63.71%1.23B
FY201531 Dec 2015790.00M-6.51%10.57%4.56B61.04%360.00M
FY201431 Dec 2014845.00M-2.99%11.45%4.59B62.17%433.00M
FY201331 Dec 2013871.00M-12.37%12.19%4.54B63.49%721.00M
FY201231 Dec 2012994.00M-11.49%13.71%4.56B62.91%-3.16B
FY201131 Dec 20111.12B+4.66%14.73%4.68B61.43%1.64B
FY201031 Dec 20101.07B-17.65%13.75%4.79B61.32%149.00M
FY200931 Dec 20091.30B+0.62%15.91%5.18B63.21%-108.00M
FY200831 Dec 20081.30B+9.75%16.09%5.09B63.23%-699.00M
FY200731 Dec 20071.18B-4.45%14.12%5.40B64.60%940.00M
FY200631 Dec 20061.24B-38.98%15.79%5.08B65.00%-2.32B
FY200531 Dec 20052.02B+14.29%32.21%4.75B75.52%1.30B
FY200431 Dec 20041.77B+154.09%31.49%4.28B76.05%1.83B
FY200331 Dec 2003697.00M+14.26%20.05%2.52B72.35%930.00M
FY200231 Dec 2002610.00M+510.00%20.90%2.05B70.20%856.00M
FY200131 Dec 2001100.00M-85.19%3.74%1.75B65.62%614.00M
FY200031 Dec 2000675.00M-6.90%25.34%1.92B72.15%856.00M
FY199931 Dec 1999725.00M—25.51%1.94B68.33%903.00M
FY199831 Dec 1998-222.40M-153.62%-9.96%1.57B70.50%620.00M
FY199731 Dec 1997414.80M+21.36%22.15%1.41B75.23%509.00M
FY199631 Dec 1996341.80M+19.93%23.38%1.12B76.77%411.80M
FY199531 Dec 1995285.00M+119.23%25.75%830.00M74.98%299.90M
FY199431 Dec 1994130.00M+19.71%28.96%295.80M65.89%139.00M
FY199331 Dec 1993108.60M+17.03%28.57%246.20M64.77%115.00M
FY199231 Dec 199292.80M+31.63%29.44%203.30M64.50%97.40M
FY199131 Dec 199170.50M—30.65%151.60M65.91%73.90M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Boston Scientific's operating income

Source: Financial Modeling Prep